Goodpasture syndrome during the course of a Schönlein-Henoch purpura

Chronic Kidney Disease: Common, Harmful and Treatable – World Kidney Day 2007

“…CKD is defined as either kidney damage, estimated from markers such as albuminuria, or glomerular filtration rate (GFR) <60 ml/min/1.73 m 2 for 3 months or more [1,2,3]. Albuminuria is usually defined as spot urine protein-to-creatinine ratio >30 mg/g and GFR is usually estimated from serum creatinine, age, sex and race.…”

“…Increasing thickness of arrows connecting later stages to complications represents the increased risk of complications as kidney disease progresses. Modified and reprinted with permission [1,2,3]. …”

“…Indeed, recent studies show that patients with CKD are 100 times more likely to die, principally from CVD, than to develop kidney failure [7]. There are now convincing data for efficacy of treatment to prevent complications of decreased GFR, to slow progression of kidney disease, and to reduce CVD risk [1,2,3]. Testing for CKD is feasible in clinical practice and the same methods can be applied in large-scale screening of people at increased risk.…”

“…CKD testing can be implemented within the same infrastructure used for CVD risk factor testing, and should include an assessment for albuminuria and a serum creatinine measurement to estimate GFR [1, 3, 5]. These measures should detect most cases of CKD in adults due to hypertension and diabetes.…”

Anti-Glomerular Basement Membrane Disease Accompanied by Membrano Proliferative Glomerulonephritis: A Case Report

“…The association of anti-GBM disease and ANCA-associated vasculitis is not uncommon [5]. Likewise, concurrent occurrence of anti-GBM disease with other types of glomerulonephritis such as membranous and IgA nephropathy and Henoch-Schonlein purpura have been described in several case studies [6][7][8][9][10][11]. Membranous nephropathy is the most commonly reported immune-complex glomerulonephritis that accompanies anti-GBM disease.…”